New aspects of iron therapy in patients with renal insufficiency;Neue aspekte der adjuvanten eisentherapie

Nieren- und Hochdruckkrankheiten

Volumn 30, Issue 2, 2001, Pages 84-90

  Kosch, M ^a   Schaefer, R M ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Chronic renal failure; Diagnosis of iron status; Intravenous iron supplementation; Renal anemia; Therapy guidelines

Indexed keywords

CHRONIC KIDNEY FAILURE; DIALYSIS; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY FAILURE; REVIEW; TRANSFERRIN BLOOD LEVEL; TREATMENT INDICATION;

EID: 0035112299     PISSN: 03005224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Iron deficiency in maintenance hemodialysis patients: Assessment of diagnosis criteria and of three different iron treatments
2. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients
3. Impaired neutrophil defense against Yersinia enterocolitica in patients with iron overload who are undergoing dialysis
4. Iron deficiency in the United States
5. Iron balance in hemodialysis patients
6. European best practice guidelines for the management of anaemia in patients with chronic renal failure
7. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin
8. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
9. The safety of intravenous iron dextran in hemodialysis patients
10. Impairment of phagocyte oxidative metabolism in hemodialyzed patients with iron overload
11. Intravenous iron dextran in clinical medicine
12. How to diagnose and correct iron deficiency during r-HuEPO therapy - A consensus report
13. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era
14. Erythropoietin and iron
15. Hypotransferrinemia of chronically hemodialyzed patients
16. Dialyzer blood loss
17. A clinical evaluation of serum ferritin as an index of iron stores
18. The relative contribution of measured variables to death risk among hemodialysis patients
19. Detection of functional iron deficiency during r-HuEPO treatment: A new approach
20. Characterization of iron availability from 3 different intravenous iron preparations in dialysis patients
21. Treating renal anaemia with r-HuEPO: Practical guidelines and a clinical algorithm
22. A randomized controlled study of iron supplementation in patients treated with erythropoietin
23. Specific problems of renal anemia in childhood
24. Hemolysis and blood loss in children with chronic renal failure
25. Clinical practice guidelines for the treatment of anemia of chronic renal failure
26. The hypochromic red cell: A new parameter for the monitoring of iron supplementation during r-HuEPO therapy
27. Intravenous ferric saccharate as an iron supplement in dialysis patients
28. Safety of intravenous injection of iron saccharate in hemodialysis patients
29. Erythropoietin and iron
30. Erythropoetin hyporesponsiveness: From iron-deficiency to iron overload
31. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin
32. "Oversaturation" of transferrin after intravenous ferric gluconate (Ferrlecit) in hemodialysis patients